FDA Peptide Regulatory Update — June 2026 is part of the Novusyn Research editorial desk. Monthly FDA regulatory brief: 12-peptide Category 1 reclassification, 503B Bulk List update, and Harbin Jixianglong import alert. This prerendered HTML exists so crawlers see route-specific content before the client app hydrates.
For adjacent coverage, see the news desk, clinical trials tracker, regulation tracker, guides library, and the compound directory. Novusyn Research publishes neutral, research-only reference material and does not sell compounds or provide medical advice.